Novartis has announced that it will be expanding its late-stage cardiovascular pipeline by acquiring Anthos Therapeutics for ...
Boehringer Ingelheim (BI) has announced positive top-line results from a late-stage study of its investigational ...
CSL Behring has shared positive four-year results from a late-stage study of its haemophilia B gene therapy Hemgenix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback